Biotomo Technology Platform

Biotomo trading as Biomimetics(Au) has developed a range of bone repair and regeneration materials that have superior bioactivity and strength which can be successfully used in load bearing applications.
.

Natural bone consists of approximately 70% inorganic material that resembles synthetic Hydroxyapatite (calcium phosphate) with interconnected pore structure of 100 - 500 micron to allow vascularisation and bone growth. BioTomo Pty Ltd utilizes a synthetic bone like material of 150 to 400 micron pore size with appropriate interconnectivity and mechanical strength. With a transformative innovation, biomaterials can be coated with bone-like carbonate apatite thin films using our unique nanotechnology. These materials can be coated onto surfaces of any size and shape.

This process preserves the larger interpores necessary for successful osseo-integration. Increased surface area generated with this coating increases both the strength and bioactivity and hence produces better and accelerated bonding to the natural bone, faster healing and reduced hospitalization.

Natural bone has osteoinductivity that allows new bone growth both internal and external structures. All biocompatible synthetic materials are osteoconductive as scaffolds and allow only external surface reactivity and growth. Biomimetics’ biomaterials are all carbonate hydroxyapatite material with osteoinductive properties similar to the natural bone that is not observed in any other synthetic material currently available in the market place.

In addition this uniquely structured bone graft material with natural bone like chemistry and fine interconnected porous architecture may be used for drug elution and dissolution in appropriate applications.

The company’s inventive technology platform and their advantages include: